Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04749368
Status:
COMPLETED
Last Update Posted:
2024-06-18
First Post:
2021-02-07
Brief Title:
Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus HBV Infection
Sponsor:
Brii Biosciences Limited
Organization:
Brii Biosciences Limited
Study Overview
Official Title:
A Phase 2 Multicenter Randomized Open-label Study to Investigate the Safety and Efficacy of BRII-835 VIR-2218 and BRII-179 VBI-2601 Combination Therapy for the Treatment of Chronic Hepatitis B Virus HBV Infection
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open label randomized parallel-group study to evaluate the safety and efficacy of combination treatment BRII-835 VIR-2218 and BRII-179 VBI-2601 in adult participants with chronic HBV infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None